Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Multigene Testing for Hereditary Cancer: When, Why, and How.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 May 2017

Offit Kenneth

Abstract excerpt

Multigene testing is a complicated area, with advantages and disadvantages of testing for hereditary cancer syndromes. Currently, NCCN does not endorse routing multiplex testing outside of a research setting, and/or intensive genetic counseling regarding risks and benefits. The 2017 NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian and Colorectal provide...

Topics

Join the communities discussing this publication.

Genes, Neoplasm
Genetic Predisposition to Disease
Genetic Testing
Molecular Diagnostic Techniques
Neoplastic Syndromes, Hereditary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Practice Guidelines as Topic

Source

Identifiers

PMID: 28515260
DOI: 10.6004/jnccn.2017.0089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multigene Testing for Hereditary Cancer: When, Why, and How.PMID 28515260Read ↗

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.Semantic proximity Read ↗

Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.Semantic proximity Read ↗

Strategies for clinical implementation of screening for hereditary cancer syndromes.Semantic proximity Read ↗

Inherited Cancer in the Age of Next-Generation Sequencing.Semantic proximity Read ↗

Should all patients undergoing genetic testing for hereditary breast cancer syndromes be offered a multigene panel?Semantic proximity Read ↗

[Diagnosis of Hereditary Tumors Using Multi Gene Panel Testing(MGPT)-Current Status and Issues in Japan or Worldwide].Semantic proximity Read ↗

Principles of molecular testing for hereditary cancer.Semantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multigene panel testing.Semantic proximity Read ↗

Cancer risk assessment using genetic panel testing: considerations for clinical application.Semantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multi-gene panel testingSemantic proximity Read ↗

Changes in multi-gene cancer panels for children: A 4-year retrospective review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.